You are currently browsing:

Eli Lilly announces Verzenio survival benefit

Breast Cancer Ireland applauds this new breakthrough as Eli Lilly and Company has announced that its CDK4 & 6 inhibitor Verzenio (abemaciclib) has been found to significantly extend life in women with HR+, HER2- advanced breast cancer. To read more about this, click the link below: http://www.pharmatimes.com/news/eli_lilly_announces_verzenio_survival_benefit_1295959?fbclid=IwAR1_QRfAIuOZ6HgZ6zzOEb5exIPc1l9v9h0WIrN8X1HkAX8d2HYbwW1GHi0

Read More

AI reveals new breast cancer types that respond differently to treatment

Scientists at The Institute of Cancer Research have used artificial intelligence to recognize patterns in breast cancer, and have uncovered five new types of the disease each matched to different personalised treatments as a result. To read more about this exciting discovery, click the link below: https://medicalxpress.com/news/2019-08-ai-reveals-breast-cancer-differently.html?fbclid=IwAR2SU0WErf7vaUdw1iX2XQyBqdOQVsgR9r2nWHnnWvXCLtaLy-W2Lkrl024

Read More

Hope for aggressive breast cancers as diabetes drug creates new potential avenue for treatment

Research has shown that metformin – commonly used to treat Type 2 diabetes – could make breast cancer cells susceptible to new treatments. Breast Cancer Ireland applauds this new development. To read more about this exciting news, click the below link: https://breastcancernow.org/news-and-blogs/news/hope-for-aggressive-breast-cancers-as-diabetes-drug-creates-new-potential-avenue-for-treatment?fbclid=IwAR0wacc0Fl6OimhZ96AujCFhGjYBCFV8xkBklFD6L8O29ABVnh6jlBRH-H4#.XTWsQxisjkk.email

Read More

Talzenna bags EU approval for gBRCA-mutated breast cancer

An important milestone in breast cancer treatment has been reached as the European Commission announced the approval of Pfizer’s Talzenna for patients with inherited BRCA-mutated locally advanced or metastatic breast cancer. To learn more about this important approval, click the link below: http://www.pharmatimes.com/news/talzenna_bags_eu_approval_for_gbrca-mutated_breast_cancer_1292259?fbclid=IwAR0vDYAm_zBuOopYI69k2izCEkeU_kHgKbqTKroxOmAG5pmf2l9RZTujRE4

Read More
X